- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-mer
 - Ligands
 - 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.16: 2 residues within 4Å:- Chain A: Y.28, N.61
 
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain A: N.282
 - Chain C: K.558
 
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.603
 
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: N.616, Q.644
 
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: H.655, N.657
 
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: N.709, I.1130, G.1131
 
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain A: A.706, E.1072, K.1073, N.1074
 
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain A: N.165
 
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: Y.28, N.61
 
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain B: E.281, N.282
 
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain B: N.603
 
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain B: N.616
 
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: H.655, N.657
 
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: N.709, I.1130, G.1131
 
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain B: A.706, E.1072, K.1073, N.1074
 
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain B: N.165
 
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain C: Y.28, N.61
 
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain C: E.281, N.282
 
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain C: N.603
 
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain C: N.616
 
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain C: N.657
 
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: N.709, I.1130, G.1131
 
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain C: A.706, E.1072, K.1073, N.1074
 
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain C: Q.115, E.132, N.165, T.167
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Dejnirattisai, W. et al., The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell (2021)
          


 - Release Date
 - 2021-03-03
 - Peptides
 - Spike glycoprotein: ABC
COVOX-159 Fab heavy chain: DFH
COVOX-159 Fab light chain: EGI - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
FH
HE
EG
GI
L 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-mer
 - Ligands
 - 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Dejnirattisai, W. et al., The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell (2021)
          


 - Release Date
 - 2021-03-03
 - Peptides
 - Spike glycoprotein: ABC
COVOX-159 Fab heavy chain: DFH
COVOX-159 Fab light chain: EGI - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
FH
HE
EG
GI
L